Unlocking Cures for Pediatric Cancer With Artificial Intelligence
- Executive Order Number
- 14355
- President
- Donald Trump
- Signed
- September 30, 2025
- Published
- October 7, 2025
- Source
- Federal Register
- Original Document
- https://www.govinfo.gov/content/pkg/FR-2025-10-07/pdf/2025-19495.pdf
AI-Generated Summary
Summary of Executive Order on Harnessing Artificial Intelligence to Combat Pediatric Cancer
Purpose
The executive order aims to leverage artificial intelligence (AI) to advance the prevention, diagnosis, treatment, and cure of pediatric cancer, which is the leading cause of disease-related death for children aged 1-19 in the United States. It builds on existing initiatives like the Childhood Cancer Data Initiative (CCDI) and the Make America Healthy Again (MAHA) Commission to drive innovation, improve data infrastructure, and integrate AI into healthcare and research to save lives and address the increasing incidence of childhood cancer.
Key Actions or Directives
- Harnessing AI Innovation: The MAHA Commission, in coordination with the Secretary of Health and Human Services, the Assistant to the President for Science and Technology (APST), and the Special Advisor for AI and Crypto, shall develop AI-driven solutions for pediatric cancer. This includes accelerating progress at the CCDI by focusing on:
- Improving data infrastructure for AI analysis and clinical trial participant selection.
- Enhancing data analysis with AI for predictive modeling, biomarkers, and treatment optimization.
- Improving clinical trial design, access, and outcomes using multimodal data and AI.
- Increasing Investment and Engagement: The MAHA Commission, with relevant officials, shall prioritize expanding research and care by:
- Increasing federal funding for CCDI and other initiatives.
- Encouraging private sector use of advanced technologies, including AI, for cancer cures.
- Improving Data Sharing and Patient Empowerment: The Secretary, in consultation with the APST, shall integrate AI into interoperability efforts, ensure patient control over health data, and finalize standards for safe, privacy-compliant data exchanges involving structured and unstructured data.
Significant Changes to Policy or Law
The order does not introduce new laws but directs existing agencies and commissions to prioritize AI integration into pediatric cancer research and care. It expands on prior initiatives (e.g., CCDI from 2019 and MAHA Commission from Executive Order 14212) by mandating AI-focused strategies, increased federal investments from existing funds, and enhanced data interoperability standards, while aligning with America's AI Action Plan. No new funding is appropriated; implementation is subject to available appropriations.
Potential Impacts
- On Government Agencies: Agencies like the Department of Health and Human Services, National Institutes of Health, and Office of Management and Budget will see increased coordination and resource allocation toward AI-enhanced cancer research, potentially accelerating data initiatives and clinical advancements.
- On Citizens: Patients, families, and researchers may benefit from improved diagnostics, treatments, and clinical trials, with better data privacy and access, potentially leading to reduced cancer mortality and long-term effects for children and young adults.
- On International Relations: The order focuses domestically but could indirectly influence global health research collaborations by promoting U.S. leadership in AI-driven medical innovation, without explicit international directives.
Main Stakeholders
- Government Entities: MAHA Commission, Department of Health and Human Services, National Institutes of Health, Office of Management and Budget, APST, Special Advisor for AI and Crypto, and National Cancer Institute-Designated Cancer Centers.
- Private Sector: Technology companies, researchers, and healthcare providers encouraged to adopt AI for cancer solutions.
- Citizens and Patients: Children, adolescents, young adults with cancer, their families, and clinicians benefiting from enhanced research, data tools, and patient-controlled health information.
- Researchers and Academics: Those involved in AI, data analysis, and clinical trials at federal and private institutions.
Notable Legal, Constitutional, or Political Implications
- Legal: The order is implemented consistent with existing laws and appropriations, with no creation of enforceable rights or benefits. It references 15 U.S.C. 9401(3) for the AI definition and ensures privacy protections in data sharing.
- Constitutional: Issued under presidential authority from the Constitution and U.S. laws, it does not impair agency authorities or OMB functions, maintaining separation of powers.
- Political: Reinforces administration priorities on health innovation and AI, potentially fostering bipartisan support for childhood cancer efforts while encouraging public-private partnerships, though dependent on funding availability which could spark debates on budget priorities.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.